Penny Stocks
IMNN: ThermoDox Deal Gives a Written-Off Asset a New Path
IMUNON’s proposed ThermoDox sale offers contingent future value while management focuses on its Phase 3 ovarian-cancer program.
Read the storyTagged: IMNN
STORIES WITH TASTE
IMUNON’s proposed ThermoDox sale offers contingent future value while management focuses on its Phase 3 ovarian-cancer program.
Read the story